Introduction {#s1}
============

Through the bite of an infected mosquito, the mammalian host is infected with *Plasmodium* sporozoites, which migrate through the skin to invade blood vessels. Sporozoites are then carried by the blood flow to the liver, where they initiate a liver- and subsequently a blood-stage infection ([@bib24]). Sporozoite motility, a substrate-dependent gliding motility, is essential for the exit from the dermis, and as a result for sporozoite infectivity ([@bib25]; [@bib1]; [@bib14]; [@bib10]). In comparison to fast migrating mammalian cells, such as lymphocytes, which crawl at approximately 0.1 μm/s, sporozoites move at 1--3 μm/s ([@bib1]; [@bib14]; [@bib10]). Given the energy cost of such a remarkable speed, fast migration is likely key for sporozoite infectivity. Gliding speed is affected by the turnover of focal adhesion sites ([@bib20]), as well as by environmental obstacles present in the dermis ([@bib14]). While on two-dimensional substrates in vitro, salivary gland sporozoites glide in a circular pattern. In the dermis, this motion is transformed to a complex non-linear path ([@bib1]; [@bib14]).

Recent work has shown that both the circumsporozoite protein (CSP) and the thrombospondin-related anonymous protein (TRAP) have important roles for the exit of *Plasmodium berghei* sporozoites from the dermal inoculation site ([@bib9]; [@bib10]). Proteolytic processing of CSP leads to removal of the N-terminus and exposure of a cell-adhesion domain ([@bib9]). Sporozoites expressing a mutant CSP which lacks the N-terminus (CSΔN), thus mimicking the proteolytically processed form of CSP, display normal infectivity when inoculated intravenously ([@bib9]). However, when CSΔN sporozoites are injected intradermally, parasites are undetectable in the liver and exhibit a significant delay in the prepatency period, indicating that CSΔN parasites are impaired in their ability to exit the dermis ([@bib9]). CSΔN sporozoites show only a small reduction in gliding motility in vitro ([@bib9]), suggesting that these mutant sporozoites have additional impairments in vivo. Mutant TRAP-VAL parasites carry mutations in the putative rhomboid-cleavage site of TRAP and similar to the CSΔN mutant, they have a more dramatic reduction in their infectivity after intradermal inoculation, compared to intravenous inoculation ([@bib10]). Unlike the CSΔN sporozoites, TRAP-VAL sporozoites display a significantly reduced gliding speed in vitro, moving at approximately 0.5 μm/s in vitro ([@bib10]).

Here, we present a quantitative in vivo study on the motility of *Plasmodium* sporozoites over time, and by visualization of dermal vascular endothelia we describe their interaction with dermal blood vessels. We characterize changes in sporozoite motility over the first 2 hr after intradermal inoculation and identify an altered type of sporozoite motility in proximity of blood vessels. We rendered the CSΔN and TRAP-VAL sporozoites fluorescent in order to study the function of these surface proteins in dermal parasite motility and blood vessel recognition and found that CSΔN sporozoites spend more time engaging with blood vessels, yet are unable to enter the blood circulation. Imaging TRAP-VAL sporozoites, we find that their slow gliding speed significantly decreases the volume of tissue explored, which likely results in reduced ability to encounter blood vessels.

Results {#s2}
=======

Sporozoite motility at the dermal inoculation site is increasingly constrained over time {#s2-1}
----------------------------------------------------------------------------------------

To quantitatively assess sporozoite motility over the first 120 min after inoculation into the skin of a mouse, we generated *P. berghei* sporozoites expressing the fluorescent protein mCherry under the control of a strong sporozoite-stage promoter ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}) and visualized them in the ear pinna. 4-min time-lapse stacks were acquired 5 min, 10 min, 20 min, 30 min, 60 min, and 120 min after intradermal inoculation (see [Video 1](#video1){ref-type="other"}) and the paths of migrating sporozoites were manually tracked using Imaris software. Reconstructed tracks were re-centered by plotting to a common origin ([Figure 1A](#fig1){ref-type="fig"}), which revealed a gradual decrease in parasite dispersal over the first 120 min after inoculation. The mean square displacement (MSD) reflects the dissemination of a motile population from their origin ([@bib5]). To characterize changes in sporozoite dissemination over the first 120 min after inoculation, the MSD of sporozoites was plotted over time. Highest dispersals were seen within the first 15 min after intradermal inoculation ([Figure 1B](#fig1){ref-type="fig"}). Over the following 110 min, parasite dispersal gradually decreases, which is reflected in a gradual reduction of the slope obtained from linear regression fitting of the MSD plot ([Figure 1B](#fig1){ref-type="fig"}, inset).Video 1.Time-lapse microscopy of wild-type control *P. berghei* sporozoites from 5 min to 120 min after intradermal inoculation.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.003](10.7554/eLife.07789.003)10.7554/eLife.07789.00310.7554/eLife.07789.004Figure 1.Sporozoite motility is increasingly constrained over time and is not well described by a Brownian walk.Time-lapse microscopy of sporozoites was started at the indicated time points after intradermal inoculation and 4 min long videos were acquired. See [Video 1](#video1){ref-type="other"} for a representative time course. (**A**) Meandering and linearly moving sporozoites were manually tracked using Imaris software and for each time point 11 representative reconstructed tracks were plotted to a common origin to visualize parasite dispersal over time. For panels **B**--**F**, a varying number of videos were processed for each time point after inoculation: 5 min (2 videos/37 tracks), 10 min (14 videos/179 tracks), 20 min (7 videos/95 tracks), 30 min (9 videos/129 tracks), 60 min (8 videos/77 tracks), and 120 min (7 videos/67 tracks). (**B**) Mean square displacement (MSD) of sporozoite tracks over the duration of the 4 min video, at indicated time points after inoculation, with inset showing the slope obtained through linear regression fitting of MSD curves. (**C**) The probability distribution P(r) of squared final sporozoite displacements at the end of the 4-min videos. For comparison, the distribution of a Brownian walk is shown. (**D**) Apparent speed of gliding sporozoites. Bars represent mean values and dashed line marks the mean value at 5 min after inoculation. (**E**) The percentage of sporozoites gliding continuously in the same circle throughout the duration of the video, showing an increasing proportion of exclusively circling sporozoites at later time points. Every data point represents one video. (**F**) Straightness of sporozoite tracks, the ratio of displacement to track length of both meandering and linearly moving, as well as continuously circling sporozoites. Bars represent mean values and dashed line marks the mean value at 5 min after inoculation.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.004](10.7554/eLife.07789.004)10.7554/eLife.07789.005Figure 1---figure supplement 1.Absolute number of sporozoites exhibiting different motility patterns over time.Data from two complete time courses were combined and shown is the absolute number of total sporozoites at the inoculation site at each time point and of these, the number that are non-motile, continuously circling and meandering.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.005](10.7554/eLife.07789.005)10.7554/eLife.07789.006Figure 1---figure supplement 2.Motility is increasingly constrained over time after sporozoite inoculation by mosquito bite.A mosquito infected with *Pb*mCherry sporozoites was allowed to probe on the ear pinnae of an anethesized mouse and the first 4-min time-lapse was acquired 3 min after the proboscis was seen in the field of view. The bite site was followed for a total of 110 min, and images were acquired at the indicated times. Data shown was obtained from two biological replicate time courses. (**A**) Sporozoites were manually tracked using Imaris software to compare the MSD of sporozoites at 3 min (38 tracks), 10 min (30 tracks), 20 min (73 tracks), 40 min (53 tracks), 60 min (61 tracks), and 110 min (1 video only/21 tracks) after mosquito bite. (**B**) Proportion of manually counted sporozoite motility patterns are shown as percent of total sporozoites. Data from two independent experiments are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.006](10.7554/eLife.07789.006)10.7554/eLife.07789.007Figure 1---figure supplement 3.Generation and verification of a marker-free *Plasmodium berghei* line expressing mCherry under control of the uis4 promoter, using GIMO transfection.(**A**) Schematic representation of the introduction of an mCherry-expression cassette under the control of uis4-promoter into the GIMO~PbANKA~ mother line 1596cl1. Transfection construct pL1937 containing the *uis4-mCherry-3ʹpbdhfr* cassette is integrated into the modified *P. berghei* 230p locus containing the h*dhfr*::y*fcu* selectable marker cassette (black box) by double cross-over homologous recombination at the target regions (hatched boxes). Negative selection with 5-FC selects for parasites that have the mCherry reporter introduced into the genome and the h*dhfr*::y*fcu* marker removed (PbANKA~mCherry~ line 2204). Location of primers used for PCR analysis and sizes of PCR products are shown. (**B**) Diagnostic PCRs confirm integration as expected in PbANKA~mCherry~ line 2204 clone 5, shown by the absence of the h*dhfr*::y*fcu* marker (amplification of h*dhfr*::y*fcu* with primers 4698/4699) and correct 5′- and 3′-integration PCR product sizes (primer pairs 5510/4958 and 5515/5511, respectively). See [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} for all primer sequences.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.007](10.7554/eLife.07789.007)

Since the distribution of displacements is more sensitive to the nature of the migration than the MSD, we determined the probability that a sporozoite would reach a given final displacement at different time points after inoculation. This allowed us to ascertain whether sporozoite dissemination mimics that of a Brownian walk. The distribution of this probability P(r) was plotted in a normalized histogram ([Figure 1C](#fig1){ref-type="fig"}), and it was found that the migration of sporozoites is not well described by an ordinary random walk. In particular, the probability of large displacements is much higher than would be expected for a Brownian walk ([@bib13]) ([Figure 1C](#fig1){ref-type="fig"}). Importantly, the analysis of sporozoite displacement only included sporozoites predominantly moving in linear or meandering patterns.

While the ability of sporozoites to disperse decreases significantly after 20 min and further during the following 100 min, the apparent gliding speed does not change significantly until 60 min after inoculation ([Figure 1D](#fig1){ref-type="fig"}), which shows that the decrease in MSD is not merely a reflection of sporozoites moving more slowly. This prompted us to look at the pattern with which sporozoites move at the different time points. Over time, an increasing number of parasites engage in continuous circular motility ([Figure 1E](#fig1){ref-type="fig"}). While at early time points, this sporozoite behavior is seen less frequently, at 20 min and 30 min after inoculation, approximately 22% and 36% of total sporozoites exhibit continuously circling motility. Importantly, at these time points the increased percentage of circling sporozoites is not the result of the other motile sporozoites leaving the field, but rather an increase in the absolute number of sporozoites that are exclusively circling ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). However, by 60 and 120 min, there are 20 and 40% fewer sporozoites in the field, respectively, and an increased number of non-motile sporozoites. Thus, at 120 min almost all moving sporozoites are circling ([Figure 1E](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

Our analysis shows that the change in sporozoite trajectories at 20 and 30 min was not due to their slowing down ([Figure 1D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). To better understand this increase in parasite confinement, track straightness was calculated. Track straightness is defined as the ratio of displacement to track length ([@bib5]), and smaller ratios reflect more constrained tracks, while straight tracks are characterized by large ratios. This analysis included the entire population of motile sporozoites (meandering sporozoites, as well as sporozoites continuously moving in the same circle). As shown in [Figure 1F](#fig1){ref-type="fig"}, the straightness of sporozoite tracks gradually decreases over the first 120 min after inoculation with the most significant decrease seen beginning at 20 min after inoculation. These data suggest that sporozoite motility changes over time such that after an initial phase of maximal dispersal, sporozoites move in more constrained circular paths. Of note, a similiar change in sporozoite motility was seen in data acquired from sporozoites imaged after inoculation by a probing infected mosquito, with a significant drop in MSD 20 min after mosquito bite and a concomitant increase in the number of sporozoites engaging in circular motility (see [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Though these data suggest that overall, the pattern of motility is similar whether sporozoites are deposited by mosquito bite or needle; additional experimentation is needed to provide more quantitative data. Unfortunately, these data are more difficult to acquire because of technical issues in finding and capturing, by video-microscopy, sporozoites inoculated by a probing mosquito.

Sporozoites recognize dermal CD31+ blood vessels {#s2-2}
------------------------------------------------

In order to exit the skin and enter the blood circulation, sporozoites must encounter and penetrate blood vessels. Although it was initially postulated that sporozoites might also reach the liver via the lymphatic vessels, a previous study found that sporozoites entering lymphatic vessels in the skin do not travel beyond the draining lymph node, and thus do not participate in liver stage infection ([@bib1]; [@bib22]). To characterize the ability of sporozoites to engage with dermal vasculature, we visualized vascular endothelia by labeling the pan-endothelial junction molecule CD31 (also designated as platelet endothelial cell adhesion molecule 1, PECAM-1) by intravenous injection of fluorescently labeled rat anti-CD31 ([@bib12]). CD31 is a member of the immunoglobulin superfamily and is present on the surface of endothelial cells of both lymphatics and blood vessels, where it is a constituent of intercellular junctions. However, as we performed our experiments within 2--3 hr of intravenous inoculation of anti-CD31, lymphatics were not labeled in our studies, since it takes ∼24 hr for intravenously inoculated antibody to get into the extravascular space and taken up by lymphatic vessels ([@bib23]). This was confirmed by labeling lymphatic vessels with antibodies against the lymphatic vessel endothelial receptor 1 (LYVE-1) ([@bib17]), which in the time frame of our experiments revealed no co-localization with CD31 ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Additionally, lymphatic vessels, being wider and flatter and frequently possessing blind endings, have a different shape than blood vessels.

We observed sporozoites gliding in close proximity to CD31-labeled vessels and frequently found sporozoites gliding in parallel to or in circular paths around the vessel ([Figure 2A](#fig2){ref-type="fig"} and [Video 2](#video2){ref-type="other"}). Surprisingly, sporozoites do not immediately penetrate blood vessels after contacting them. Instead, they move on and around vessels for significant periods of time, frequently even detaching from vessels and moving back into avascular areas of the tissue ([Figure 2A](#fig2){ref-type="fig"} and [Video 2](#video2){ref-type="other"}). We quantified the time sporozoites spend in proximity to blood vessels and found that on average, sporozoites spend 28% of their gliding time near or on vessels, which in our 4-min videos correspond to over a minute of total gliding time.10.7554/eLife.07789.008Figure 2.Sporozoites recognize dermal blood vessels.Time-lapse microscopy of sporozoites, 10 min after intradermal inoculation, and CD31-labeled vascular endothelia. (**A**) Maximum intensity projection over 240 s shows trajectories of moving sporozoites (green) and blood vessels (far red) (see [Video 2](#video2){ref-type="other"}). Sporozoites were manually tracked using Imaris software and tracks overlapping with CD31+ vessels are colored orange, while tracks in between CD31+ vessels are white. Scale bar, 25 μm. For panels **B**--**D**, 18 videos were processed and 313 tracks of sporozoites moving in proximity of blood vessels and 163 tracks of sporozoites moving in between blood vessels were generated. (**B**) Apparent speed, with lines representing mean values, reveals a decrease in gliding speed once sporozoites are in proximity of blood vessels. (**C**) MSD plot shows significant decrease in displacement of sporozoite tracks in the vicinity of vasculature. Inset shows decreased slope of perivascular tracks obtained from linear regression fitting (R^2^ values: R~perivascular~ = 0.9884; R~avascular~ = 0.9924). (**D**) Extrapolated track curvature, as defined by 1/radius (where the radius is measured in μm), of perivascular and avascular sporozoite tracks. Kolmogorov--Smirnov two-sample test was performed and found difference of perivascular and avascular curvature highly significant (p = 10^−57^). Shaded area shows range of curvature of dermal capillaries ([@bib27]; [@bib6]).**DOI:** [http://dx.doi.org/10.7554/eLife.07789.008](10.7554/eLife.07789.008)10.7554/eLife.07789.009Figure 2---figure supplement 1.Anti-CD31 does not stain lymphatic vessels early after its inoculation.Dual live immunostaining for the lymphatic vessel hyaluronan receptor-1 and the panendothelial marker CD31. Lymphatic vessels (green) are labeled with anti-mouse LYVE-1 (clone ALY7, Affymetrix), inoculated intravenously 24 hr prior to imaging. Anti-mouse CD31 AF-64 was inoculated 3 hr prior to imaging and though blood vessels are stained (magenta), at this time point, lymphatic vessels remain unstained with anti-CD31.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.009](10.7554/eLife.07789.009)Video 2.Wild-type control *P. berghei* sporozoites 10 min after intradermal inoculation together with CD31-labeled vascular endothelia.Maximum projection shown in [Figure 2](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.010](10.7554/eLife.07789.010)10.7554/eLife.07789.010

To determine whether sporozoite motility changes with the encounter of a blood vessel, we manually tracked sporozoite trajectories and produced two data sets; the first for time periods in which sporozoites move in proximity to CD31-labeled structures (within ∼3 μm of the vessels) and the second for time periods of gliding in areas without CD31-labeled vessels. A representative maximum intensity projection of this tracking is shown in [Figure 2A](#fig2){ref-type="fig"} with the two data sets shown in different colors. Analysis of the two tracking sets showed that compared to sporozoites gliding independently of CD31-labeled vessels, the average apparent speed of gliding sporozoites decreases once they approach a blood vessel from 1.38 μm/s to 1.06 μm/s, and this difference is highly significant (p value \< 0.0001) ([Figure 2B](#fig2){ref-type="fig"}).

To compare the dispersal of sporozoites gliding in avascular tissue to those gliding in proximity to vascular structures, the MSD of the two populations was plotted over time. To normalize for track length in this analysis, all tracks were fragmented to 30-s intervals. As shown in [Figure 2C](#fig2){ref-type="fig"}, the displacement of sporozoites gliding on or in proximity to blood vessels is decreased, as is the slope obtained from linear regression fitting of the MSD plot ([Figure 2C](#fig2){ref-type="fig"}, inset). This is partially a result of the decrease in gliding speed of these sporozoites, but also due to an increase in sporozoite confinement. This is demonstrated by an analysis of the curvature of sporozoite tracks, which is the curvature of the circles fitted to every 10-s interval of a given track and is defined as the inverse of the radius of that circle (see <https://github.com/kevinkchiou/Malaria-Motility> and 'Materials and methods'). The analysis revealed that while avascular tracks have little curvature, most commonly 0.077--0.125 μm^−1^, the majority of sporozoite tracks that overlap with blood vessels describe trajectories that have a curvature of 0.125--0.2 μm^−1^, which, remarkably, equals the curvature of the circumference of dermal capillaries ([Figure 2D](#fig2){ref-type="fig"}) ([@bib27]; [@bib6]). These data demonstrate that sporozoite motility can change in response to environmental signals encountered by the sporozoite and suggest that sporozoites in the dermis exhibit two types of motility: 'avascular motility', which is defined by high speed and less confinement, leading to maximal displacements in avascular areas and a more constrained 'perivascular motility', which is observed once the parasite glides in proximity of a blood vessel.

Motility of CSΔN and TRAP-VAL mutants in the dermis {#s2-3}
---------------------------------------------------

Recent work suggested that both CSP and TRAP have important roles for exit from the dermis with the demonstration that CSΔN parasites, which express a truncated form of CSP, and TRAP-VAL sporozoites, which carry mutations in the putative rhomboid-cleavage site of TRAP, have a more dramatic reduction in their infectivity after intradermal inoculation, compared to intravenous injection ([@bib9]; [@bib10]). We characterized the motility of CSΔN and TRAP-VAL sporozoites in the dermis to elucidate the function of these surface proteins in vivo, specifically focusing on parasite motility and blood vessel entry. Both mutants were generated in a drug selection cassette-free parental *P. berghei* parasite line expressing mCherry under the control of a strong sporozoite-stage promoter ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}; [Figure 3---figure supplements 1, 2](#fig3s1 fig3s2){ref-type="fig"}). CSΔN and TRAP-VAL sporozoites were imaged 10 and 30 min after intradermal injection into the ear pinna of an anesthetized mouse, and sporozoite trajectories were visualized by maximum intensity projection of the 4-min videos ([Figure 3A](#fig3){ref-type="fig"}, [Video 3](#video3){ref-type="other"} and [Video 4](#video4){ref-type="other"}). To quantify the proportion of mutant sporozoites that were motile, sporozoites were manually counted, with sporozoites being considered non-motile if they moved less than approximately 2 μm throughout the duration of the video ([Figure 3B](#fig3){ref-type="fig"}). An average of 66% of wild-type control sporozoites are motile 10 min after intradermal injection and 52% are motile at the 30 min time point. At 10 min after injection, only 47% of CSΔN sporozoites are motile, however, this number is stable over time and similar to wild-type control levels at 30 min. The analysis of TRAP-VAL sporozoites showed that only 40% and 20% of the inoculated sporozoites are motile at 10 min and 30 min after inoculation, respectively ([Figure 3B](#fig3){ref-type="fig"}).10.7554/eLife.07789.011Figure 3.Intradermal motility of CSΔN and TRAP-VAL sporozoites.Time-lapse microscopy of CSΔN and TRAP-VAL sporozoites (see [Video 3](#video3){ref-type="other"} and [Video 4](#video4){ref-type="other"}). (**A**) Maximum intensity projections of videos acquired 10 min after inoculation visualize trajectories of sporozoites. Scale bars, 50 μm. (**B**) Proportion of motile sporozoites was manually counted in videos acquired 10 min (WT, 33 videos; CSΔN, 31 videos; TRAP-VAL, 43 videos) and 30 min (WT, 8 videos; CSΔN, 11 videos; TRAP-VAL, 10 videos) after inoculation. (**C**) Apparent speed of sporozoites 10 min and 30 min after inoculation, averaged over the 4-min video.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.011](10.7554/eLife.07789.011)10.7554/eLife.07789.012Figure 3---figure supplement 1.Generation of mutant CSΔN parasites in the marker-free *P. berghei* line expressing mCherry under control of the uis4 promoter.(**A**) Schematic representation of the strategy used to replace the endogenous *CSP* locus with *CSΔN.* The transfection plasmid (pCSΔN) contains 730 bp of *CSP* 5′-UTR (thin black line), the selectable marker h*dhfr* with its 5′- and 3′-UTRs (thick black lines) and the *CSΔN* copy of the gene flanked by its 5′- and 3′-UTRs (thin black lines). Dotted gray lines indicate the location of homologous recombination with the endogenous *CSP* locus. Location of primers used for PCR analysis is shown. (**B**) Correct integration was confirmed by PCR of gDNA from the CSΔN mutant clone B3 with primers DP1 and DP2 to amplify the 5′-integration site and primers 3′int-F and 3′int-R to amplify the 3′-integration site. PCRs with primers CS-F and CS-R were used to amplify the ORF of *CSP*, resulting in a smaller product in *CSΔN* compared to the wild-type control. This PCR product was also used for sequencing to confirm the presence of the expected mutation. See [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} for all primer sequences. (**C**) Confirmation of strongly reduced infectivity of CSΔN sporozoites upon intradermal inoculation. Mice were injected with 10^4^ wild-type control or CSΔN salivary gland sporozoites, either by intravenous (IV) or intradermal (ID) injection, and 36.5 hr later, total liver RNA was extracted, and liver parasite burden was determined by RT-qPCR. There were four mice per group, and the liver parasite burden of each mouse is shown. (**D**) Western blot analysis of wild-type control and CSΔN salivary gland sporozoite lysates. The blot was cut in half, and the top was probed with polyclonal antiserum specific for TRAP as a loading control (top panel), and the bottom was probed with mAb 3D11 specific for the CSP repeat region (lower panel). Molecular mass is indicated in kilodaltons. (**E**) Fluorescence and phase-contrast images of unpermeabilized wild-type control and CSΔN salivary gland sporozoites. CSP on the surface of sporozoites was visualized by detection with mAb 3D11 specific for the CSP repeat region or polyclonal rabbit N-terminal CSP serum.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.012](10.7554/eLife.07789.012)10.7554/eLife.07789.013Figure 3---figure supplement 2.Generation of mutant TRAP-VAL parasites in the marker-free *P. berghei* line expressing mCherry under control of the uis4 promoter.(**A**) Schematic representation of the strategy used to replace the endogenous *TRAP* locus with the *TRAP-VAL* copy of the gene. The transfection plasmid (pTRAP) contains 500 bp of TRAP 5′-UTR (red line), the selectable marker h*DHFR* (black box) with its 5′- and 3′-UTRs, and the *TRAP* gene (red box) flanked by its 5′- and 3′-UTRs (red lines). Dashed black lines indicate the location of homologous recombination with the endogenous *TRAP* locus. Location of primers used for PCR analysis is shown. (**B**) Diagnostic PCRs were used to verify successful recombination at the 5′ end (primers A and B) and the 3′ end (primers C and E). Primers F and G (shown in panel **A**) were used to amplify the *TRAP* open reading frame for sequencing to confirm the presence of the desired mutations. See [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} for primer sequences. (**C**) Confirmation of reduced infectivity of TRAP-VAL sporozoites determined by prepatent period after exposure to the bites of mosquitoes infected with wild-type control or TRAP-VAL parasites.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.013](10.7554/eLife.07789.013)Video 3.Wild-type control (green) and CSΔN (far red) sporozoites 10 min after intradermal inoculation.Note that an overlay of two independently acquired videos was generated using ImageJ to allow direct comparison of WT to CSΔN sporozoite motility. Individual maximum projections shown in [Figure 3](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.014](10.7554/eLife.07789.014)10.7554/eLife.07789.014Video 4.Wild-type control (green) and TRAP-VAL (far red) sporozoites 10 min after intradermal inoculation.Note that an overlay of two independently acquired videos was generated using ImageJ to allow direct comparison of WT to TRAP-VAL sporozoite motility. Individual maximum projections shown in [Figure 3](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.015](10.7554/eLife.07789.015)10.7554/eLife.07789.015

Average speed of sporozoites was determined by manually tracking sporozoites throughout the duration of video, which includes periods of stopping and phases of continuous movement. Compared to wild-type control sporozoites, which move with an average of 1.57 μm/s, CSΔN sporozoites move with 26%-reduced average speed of 1.14 μm/s ([Figure 3C](#fig3){ref-type="fig"}). In contrast, at 10 min after inoculation, TRAP-VAL sporozoites glide much more slowly, with an average speed of 0.72 μm/s, which is a reduction of 54% compared to the wild-type control ([Figure 3C](#fig3){ref-type="fig"}) and this is further reduced to 0.42 μm/s at 30 min after inoculation.

In agreement with the reduction in gliding speed of the CSΔN and TRAP-VAL sporozoites in vivo, it became evident that 10 min after intradermal inoculation, both mutant sporozoites disperse less than wild-type control parasites, which was visualized by plotting reconstructed sporozoite trajectories to a common origin ([Figure 4A](#fig4){ref-type="fig"}). To quantitatively characterize this difference in the motility pattern, sporozoites gliding 10 min after intradermal inoculation were tracked and the MSD was plotted over time. The visibly reduced dispersal of mutant sporozoites was reflected in a decreased slope obtained from linear regression fitting of the MSD plot ([Figure 4B](#fig4){ref-type="fig"}, inset). Compared to wild-type control sporozoites, slope~WT~ = 2370, the slope of mutant sporozoites is reduced to slope~CSΔN~ = 1190 and slope~TRAP-VAL~ = 740, resulting in a decrease of over 40% and 70% of final displacement of CSΔN and TRAP-VAL sporozoites, respectively.10.7554/eLife.07789.016Figure 4.Decreased dispersal of CSΔN and TRAP-VAL sporozoites in vivo.Time-lapse microscopy of CSΔN and TRAP-VAL sporozoites. (**A**) Sporozoites were manually tracked using Imaris software and 20 representative tracks of each WT, CSΔN, and TRAP-VAL sporozoites were plotted to a common origin, revealing a decreased dispersal of mutant sporozoites. (**B**) MSD plot over time. Data shown was obtained from tracking 179 WT sporozoites (12 videos), 211 CSΔN sporozoites (29 videos), and 215 TRAP-VAL sporozoites (33 videos). Inset shows the decreased slope of mutant parasites obtained from linear regression fitting (R^2^ values: R~WT~ = 0.9926; R~CSΔN~ = 0.9890; R~TRAP-VAL~ = 0.9932).**DOI:** [http://dx.doi.org/10.7554/eLife.07789.016](10.7554/eLife.07789.016)

CSΔN and TRAP-VAL sporozoites contact dermal vascular endothelia {#s2-4}
----------------------------------------------------------------

Visualization of sporozoites and dermal blood vessels shows that sporozoites glide alongside dermal vascular endothelia and frequently circle extensively around the vessel (as seen in [Figure 2A](#fig2){ref-type="fig"} and [Video 2](#video2){ref-type="other"}). Additionally, sporozoites that are moving in proximity to blood vessels often disengage and move away from the blood vessel into avascular tissue. To quantitatively assess the time a population of sporozoites spends gliding alongside or around blood vessels, wild-type control and mutant sporozoites were manually tracked while moving in proximity to blood vessels ([Video 2](#video2){ref-type="other"}, [Video 5](#video5){ref-type="other"} and [Video 6](#video6){ref-type="other"}). Unexpectedly, it was found that compared to wild-type control sporozoites, which spend 28% of their motile time gliding in close proximity to blood vessels, CSΔN sporozoites spend significantly more time in association with dermal vascular endothelia; an average of 40.7% of their motile time is spent close to blood vessels ([Figure 5B](#fig5){ref-type="fig"}, left panel). In contrast, TRAP-VAL sporozoites spend the same proportion of their motile time gliding close to blood vessels as wild-type control parasites ([Figure 5B](#fig5){ref-type="fig"}, left panel).Video 5.CSΔN sporozoites 10 min after intradermal inoculation together with CD31-labeled vascular endothelia.Maximum projection shown in [Figure 4](#fig4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.017](10.7554/eLife.07789.017)10.7554/eLife.07789.017Video 6.TRAP-VAL sporozoites 10 min after intradermal inoculation together with CD31-labeled vascular endothelia.Maximum projection shown in [Figure 4](#fig4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.018](10.7554/eLife.07789.018)10.7554/eLife.07789.01810.7554/eLife.07789.019Figure 5.Sporozoite interaction with dermal vascular endothelia.Time-lapse microscopy of CSΔN and TRAP-VAL sporozoites 10 min after intradermal inoculation (see [Video 2](#video2){ref-type="other"}, [Video 5](#video5){ref-type="other"}, and [Video 6](#video6){ref-type="other"}). (**A**) Maximum intensity projection over 240 s reveals trajectories of WT, CSΔN, and TRAP-VAL sporozoites (green) moving in the dermis with CD31-labeled vascular endothelia (far red). Scale bars, 50 μm. For panels **B**--**D**, every data point represents one video and 18 WT, 25 CSΔN, and 24 TRAP-VAL videos were processed. (**B**) The time sporozoites spend in proximity to CD31-labeled vessels was quantified by manual tracking of sporozoites and is expressed as percent of motile time (left panel) or total observed time (right panel). Graphs show significant increase in the time CSΔN, but not TRAP-VAL sporozoites spend actively gliding on or around blood vessels. (**C**) To generate the MSD of sporozoites moving in proximity to CD31-labeled vessels, 313 WT, 352 CSΔN, and 192 TRAP-VAL tracks of sporozoites moving in proximity to CD31-labeled vessels were generated and compared to 163 WT, 121 CSΔN, and 89 TRAP-VAL tracks of sporozoites moving in avascular areas of the dermis. To calculate the MSD of the obtained sporozoite tracks with various duration times, all tracks were uniformly fragmented into tracks of 30 s in duration. MSD plot shows decrease in displacement of mutant sporozoite tracks in proximity to blood vessels. Inset shows slopes of linear regression fitting (all R^2^ values ≥0.988). (**D**) Apparent speed of wild-type control and mutant sporozoites in the proximity of blood vessels or in avascular portions of the dermis with lines representing mean values. Dashed line marks the mean value of wild-type control in avascular portions of the dermis. These data reveal a significant decrease in gliding speed of CSΔN and TRAP-VAL sporozoites, once the sporozoite is approaching vasculature, similar to wild-type control sporozoites. (**E**) Blood and lymphatic vessel invasion events were manually counted. Invasion was classified similar to previously descriptions ([@bib1]), with blood vessel invasion being defined by a sudden increase in speed or visual entry of the blood vessel and disappearance out of the field of view. Lymphatic invasion was characterized by the switch from directed forward movement to sideward drifting with a low velocity (see [Videos 7](#video7){ref-type="other"} and [Video 8](#video8){ref-type="other"}). The proportion of invading sporozoites as percent of total sporozoites in the field of view is shown. In the duration of the acquired 4 min videos, 2.38% and 2.06% of WT sporozoites invaded blood vessels and lymphatic vessels, respectively. This was in sharp contrast to the blood and lymphatic vessel invasion rates of CSΔN (0.23% and 0.26%) and TRAP-VAL (0.05% and 0%); n equals number of videos analyzed.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.019](10.7554/eLife.07789.019)10.7554/eLife.07789.020Figure 5---figure supplement 1.Blood vessel and lymphatic vessel invasion events and sporozoite MSD in videos acquired with and without CD31-labeling of dermal vasculature.(**A**) No significant difference in the number of invasion events was observed in the presence or absence of CD31-labeling of vascular endothelia. (**B**) Mean square displacement (MSD) of sporozoite tracks over the duration of 4-min videos, at indicated time points after inoculation, showing comparable displacement of sporozoites in the dermis of mice with and without CD31 labeling. Dotted line shows 10 min time point data from [Figure 1B](#fig1){ref-type="fig"}, and solid lines shows the data used for that analysis split up into data from videos with CD31 labeling and videos without. The number of videos processed was: 10 min-all videos (14 videos/179 tracks), 10 min-without CD31 (10 videos/140 tracks), 10 min-with CD31 (4 videos/39 tracks).**DOI:** [http://dx.doi.org/10.7554/eLife.07789.020](10.7554/eLife.07789.020)

To determine whether the mutant sporozoites undergo a similar switch from 'avascular motility' to 'perivascular motility' when approaching a blood vessel, we manually tracked mutant sporozoites and produced two data sets, as described above, for sporozoites moving in proximity to CD31-labeled structures and for sporozoites gliding in areas without CD31-labeled vessels. MSD analysis of the two tracking sets revealed that similar to wild-type control sporozoites, perivascular CSΔN tracks have a decreased MSD and gliding speed ([Figure 5C,D](#fig5){ref-type="fig"}), indicating that while CSΔN sporozoites spend more time gliding in proximity to vasculature, the switch from 'avascular' to 'perivascular motility' appears normal. TRAP-VAL sporozoites also exhibit differential 'avascular' and 'perivascular motility', although the differences in MSD and speed between these two types of tracks is less pronounced ([Figure 5C,D](#fig5){ref-type="fig"}).

Decreased blood vessel exit of CSΔN and TRAP-VAL sporozoites {#s2-5}
------------------------------------------------------------

Intravital microscopy of mutant CSΔN and TRAP-VAL sporozoites in conjunction with fluorescently labeled dermal vascular endothelia was performed, and invasion events were manually quantified ([Figure 5E](#fig5){ref-type="fig"}, [Video 7](#video7){ref-type="other"} and [Video 8](#video8){ref-type="other"}). Invasion was classified as previously described ([@bib1]), with blood vessel invasion defined by a sudden increase in speed or visual entry of the blood vessel and disappearance out of the field of view. It should be noted that the speed with which sporozoites appear to be carried out of the field is slower in videos that include CD31-labeling, as a result of the slower acquisition speed due to capture of two channels. Lymphatic invasion was defined by the switch from directed forward movement to sideward drifting with a low velocity. On average, in a 4-min video beginning at 10 min after inoculation, 2.38% of wild-type control sporozoites in the field of view enters the blood circulation, and 2.06% of sporozoites enters the lymphatic system ([Figure 5E](#fig5){ref-type="fig"}). Blood vessel invasion of the CSΔN mutant is reduced to 0.23% and only 0.05% of TRAP-VAL sporozoites is seen to enter into blood vessels ([Figure 5E](#fig5){ref-type="fig"}), which is consistent with the decrease in infectivity of these mutants upon intradermal inoculation ([@bib9]; [@bib10]). Invasion of the lymphatic system by CSΔN sporozoites is reduced to 0.26% and not detected at all in the case of TRAP-VAL sporozoites ([Figure 5E](#fig5){ref-type="fig"}). Importantly, CD31-labeling is not interfering with entry into dermal blood or lymphatic vessels or parasite dispersal, as vessel invasion rates, as well as sporozoite MSDs, are comparable in videos acquired in mice with and without labeled blood vessels ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).Video 7.Wild-type control sporozoites 10 min after intradermal inoculation together with CD31-labeled vascular endothelia highlighting blood and lymphatic vessel invasion events.Squares indicate blood vessel invasion and circles point to sporozoites entered into the lymphatic system. Blood vessel invasion events are characterized by a sudden increase in speed (square on the left) or visual entry of the blood vessel and disappearance out of the field of view (square on the right). Lymphatic invasion was characterized by the switch from directed forward movement to sideward drifting with a low velocity.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.021](10.7554/eLife.07789.021)10.7554/eLife.07789.021Video 8.Blood vessel invasion by wild-type control sporozoites in the absence of CD31 labeling.Imaging was performed 10 min after intradermal inoculation and squares indicate blood vessel invasion events, characterized by a sudden increase in speed.**DOI:** [http://dx.doi.org/10.7554/eLife.07789.022](10.7554/eLife.07789.022)10.7554/eLife.07789.022

This dramatic decrease in blood vessel invasion by the mutants is likely due to several factors. As shown in [Figure 4](#fig4){ref-type="fig"}, these mutants sample less of their environment; however, this is unlikely to fully explain their dramatically decreased entry into the blood and lymphatic circulations. Since only motile sporozoites are included in the calculation of MSD, it is important to consider the increased number of non-motile CSΔN and TRAP-VAL sporozoites that together with the decreased dispersal, could account for the low numbers of mutants entering the blood circulation. To look at this, we normalized the total time control and mutant sporozoites spent in proximity of blood vessels, by including all sporozoites in the field, that is, both motile and non-motile sporozoites. As shown in [Figure 5B](#fig5){ref-type="fig"} (right panel), TRAP-VAL sporozoites spend on average, 40% less time on vessels compared to wild-type control sporozoites, a decrease that is due, in part, to the large number of non-motile TRAP-VAL sporozoites. Nonetheless, the population of TRAP-VAL sporozoites still spends approximately 10% of its time on or near blood vessels, yet blood vessel entry events were reduced by 97%, suggesting that even when TRAP-VAL sporozoites do contact vessels they cannot invade them. This is even more dramatically illustrated by the CSΔN mutant that spends approximately the same total time on vessels as the control wild-type sporozoites ([Figure 5B](#fig5){ref-type="fig"}, right panel), yet blood vessel entry events were reduced by 90%. These data point to an additional impairment in blood vessel entry, that is, even when they do contact blood vessels, they cannot invade them. Indeed, both CSΔN and TRAP-VAL mutations result in the increased surface exposure of cell-adhesion domains: in CSΔN sporozoites, the absence of the N-terminus leads to constitutive exposure of the cell-adhesive type I thrombospondin domain in the C-terminus of the protein ([@bib9]) and in TRAP-VAL sporozoites, the altered proteolytic cleavage site leads to the retention of TRAP molecules on the sporozoite\'s surface ([@bib10]). Thus, the inability of these mutants to regulate their adhesive interactions likely results in their inability to complete the entry process.

Discussion {#s3}
==========

The gliding motility of *Plasmodium* sporozoites is essential for their infectivity. Previous reports have observed sporozoite motility in the dermis ([@bib1]; [@bib14]), but an in-depth analysis of their motility over time has not been performed. Intravital imaging of sporozoites over the first 120 min after inoculation highlights significant changes in their motility in this time frame. Within the first 20 min after intradermal inoculation, sporozoites displace with high speed and minimal constraint, which likely maximizes the volume of tissue that is explored by the population of sporozoites. After this initial period of dispersal, sporozoite motility changes. Most significantly starting 20 min after inoculation, the migratory pattern of sporozoites becomes increasingly confined, and a growing number of sporozoites engage in continuous circular motility. We hypothesize that this motility pattern optimizes engagement with blood vessels that will ultimately lead to blood vessel entry. 1 hr after inoculation, sporozoites begin to slow down and a significant proportion stop moving with the proportion of non-motile sporozoites increasing to 70% by 2 hr. Importantly, this late-phase slow down is distinct from the change in trajectory that occurs 20 and 30 min post inoculation when the speed and proportion of non-motile sporozoites does not change from what is observed at earlier time points. The reasons for this late-phase slow down are not known, but possibilities include resource exhaustion or encountering a host cell or factor that leads to their arrest.

In contrast to previous reports of apparently random motility of sporozoites in the dermis, which was suggested to be only environmentally constrained ([@bib1]; [@bib14]), our data show that distribution of displacements of migrating sporozoites is not Gaussian, which would be expected if sporozoites migrated in a pattern similar to a Brownian walk. Our observations of an altered sporozoite migration in proximity to blood vessels point to recognition of the vessel by the sporozoites, further demonstrating that sporozoite migration in the dermis is not well described by the statistics of a Brownian walk. This suggests that internal components or external host--pathogen interactions bias the directionality of sporozoite movement away from Brownian motion. The larger than expected displacements may allow the sporozoite to cover large distances between the blood vessels, which may enable the sporozoite to encounter blood vessels with higher efficiency than Brownian random walkers. We found that once the sporozoite approaches a blood vessel, the more linear type of motility is lost and the sporozoite switches to a more curved and confined motility. This points to a specific host--parasite interaction between the parasite and the environment of the blood vessel and provides evidence for the ability of the sporozoite to alter motility in response to host factors. Indeed, in vitro, sporozoites have been shown to respond to obstacle cues in micro-fabricated arrays so it is possible that environmental constraints alone account for the switch in the sporozoites\' migration pattern ([@bib14]). However, our observation that the sporozoites\' walk statistics change in proximity to blood vessels indicates that there is a specific recognition event that leads to this change.

Sporozoites appear to engage in two types of motility: 'avascular motility' which is likely to optimize dispersal, and 'perivascular motility' defined by more confined trajectories with increased curvature. Our analysis of track curvature reveals that sporozoites gliding in the proximity of blood vessels describe trajectories with local curvatures that interestingly relate to the curvature of the capillary vessel ([@bib27]; [@bib6]). This suggests that 'perivascular motility' enhances contact with capillaries, rather than the larger dermal terminal arterioles or post-capillary venules ([@bib27]; [@bib6]). Indeed, it has been observed previously, that the curvature of the sporozoite matches the geometry of capillaries ([@bib26]) and more recently, a study using stochastic computer simulations of sporozoite motility found that in these models, sporozoite interaction with capillaries is greatly enhanced if the parasite has the ability to adapt its curvature and torsion to the surrounding environment ([@bib4]). In addition to the change in sporozoite trajectories, we found that they also had a significant decrease in speed when in the vicinity of blood vessels. These data build upon and solidify the previous observation of Amino et al., who quantified the speed of a small number of sporozoites gliding around blood vessels and reported a decrease after contact with the vessel ([@bib1]).

Intravital imaging of mutant sporozoites that do not efficiently exit the dermis provides additional insights into the factors required for dermal exit. The importance of high sporozoite gliding speed is highlighted by the behavior of the TRAP-VAL mutant that moves with less than half the motile speed of wild-type control parasites in the dermis. This decrease in speed corresponds to the reduction of final MSD, which reduces the area of tissue explored by 70%. Consequently, TRAP-VAL sporozoites have a significantly decreased chance to encounter and invade a blood vessel, which together with the increase in number of non-motile TRAP-VAL sporozoites, largely explains their reduced infectivity ([@bib10]). Although there is no evidence for an innate host immune response that may impair the exit of sporozoites from the dermis, the observed rapid dispersal of wild-type control sporozoites suggests that the parasite has evolved to leave the skin quickly, possibly as a means to escape from phagocytic host cells ([@bib3]).

CSΔN sporozoites engage in a pattern of 'avascular' and 'perivascular motility' comparable to that of wild-type sporozoites, suggesting that while gliding in avascular parts of the dermis, their motility is normal. Of particular interest was the observed increase in the association of CSΔN sporozoites with dermal vascular endothelia. Since 'perivascular motility' is more constrained, this, together with the somewhat decreased gliding speed, explains the overall decrease in dispersal of this mutant. It was previously proposed that the function of the N-terminal portion of CSP is to mask the cell-adhesive TSR domain as sporozoites migrate through the skin and controlled proteolytic processing of CSP by a parasite protease regulates the exposure of the TSR ([@bib8], [@bib9]). We find that the constitutively exposed TSR on the surface of CSΔN sporozoites leads to increased time spent on vascular endothelia. We therefore hypothesize that the ability of the sporozoite to dynamically regulate exposure of the TSR is necessary for continued migration through the dermis, which may be crucial for the sporozoite to locate the areas of the vasculature that allow for blood vessel entry or for blood vessel entry itself. More work is needed to determine if this is the case, however, our data with both TRAP-VAL and CSΔN mutant sporozoites demonstrate that the sporozoite\'s ability to regulate its adhesive intereactions is a key factor for successful movement through and out of the dermis.

We show that wild-type control sporozoites spend over a quarter of their time engaging with blood vessels, frequently without successful entry into the blood circulation. This suggests that only certain areas of the vasculature are suitable for sporozoite entry. It is known that the abluminal surface of dermal capillaries is not uniform; for example, the basement membrane surrounding the capillary bed is not continuous and through its gaps, pericytes form tight junctions with the underlying endothelial cell ([@bib6]). Thus, there may be certain areas of the vasculature that are preferentially invaded by sporozoites.

With this study, we refine our understanding on how the sporozoite navigates through and out of the dermis. Mutant sporozoites that display modest changes in motility pattern or speed have dramatic decreases in blood vessel invasion and infectivity. These data suggest that exit from the inoculation site presents an important barrier for the sporozoite and is therefore an opportune time to intervene. Indeed, the partial success of RTS,S, the only malaria vaccine candidate in Phase III clinical trials, may result from antibodies that target sporozoites in the dermis ([@bib11]). As we build upon RTS,S, it will be important to consider expanding the antigen repertoire to include proteins critical for dermal exit. Additionally, our data suggest that an analysis of dermal sporozoite motility could be incorporated in the evaluation of future vaccine strategies to predict efficiency of new vaccine targets.

Materials and methods {#s4}
=====================

Mosquito infection {#s4-1}
------------------

*Anopheles stephensi* mosquitoes were fed on Swiss Webster mice infected with *P. berghei* ANKA wild-type control, CSΔN, or TRAP-VAL parasites as previously outlined ([@bib9]). Salivary glands were dissected 18--22 days after the infectious blood meal, homogenized in DMEM, and sporozoites were counted using a hemocytometer.

Generation of drug selection marker-free PbmCherry-expressing parasites {#s4-2}
-----------------------------------------------------------------------

The *P. berghei* ANKA line 1596cl1 was used for transfection with a construct which targets the *230p* locus (PBANKA_030600) and inserts mCherry, thereby removing the selectable marker consisting of human dihydrofolate reductase and the yeast cytosine deaminase and uridyl phosphoribosyl transferase (h*dhfr::yfcu*), according to the GIMO (gene insertion/marker out) technique, which has previously been described ([@bib18]). The transfection vector, which lacks a drug selectable marker cassette, was obtained using the targeting construct pL1628 ([@bib18]). The 5′- and 3′-regulatory elements were replaced by the 5′- and 3′-UTR of *uis4* ([@bib19]), which places mCherry under the control of this sporozoite and liver stage promoter in the new transfection construct pL1937. Transfection of 1596cl1 was performed using standard transfection methods ([@bib15]), and after transfection, negative selection was applied by treating mice with the drug 5-FC in drinking water at 1 mg/ml ([@bib21]) for four consecutive days, starting 24 hr after transfection. The resulting drug selection marker-free transfected line (2204) was cloned by limiting dilution in mice and correct integration of mCherry into the *230p* locus was demonstrated by PCR analysis using primers 5510 and 4958 to amplify the 5′ integration site, and primers 5515 and 5511 to amplify the 3′ integration site ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). The absence of the h*dhfr::yfcu* selection cassette was verified by PCR with primers 4698 and 4699 (see [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} for primer sequences).

Generation and verification of PbmCherry-CSΔN and TRAP-VAL parasites {#s4-3}
--------------------------------------------------------------------

### Transfection {#s4-3-1}

The drug selection cassette-free parasite line (*Pb*ANKA-Cherry 2204cl5), referred to as 'wild-type control', was used for transfection with CSΔN and TRAP-VAL constructs which have previously been described ([@bib9]; [@bib10]). Thus, mutant versions of *CSP* and *TRAP* with their endogenous control elements, as well as the h*dhfr* selection marker flanked by 2.2 kb of 5′UTR and 0.55 kb of 3′UTR of the pb*dhfr*-ts were introduced into the *CSP* and *TRAP* loci. Upon successful integration of the CSΔN construct, the wild-type copy of *CSP* is replaced by a truncated version lacking the amino acids NKSIQAQRNLNELCYNEGNDNKLYHVLNSKNGKIYNRNTVNRLLADAPEGKKNEK KNEKIERNNKLKQP, which encompass the entire N-terminal region, except for the signal sequence. The successful integration of the TRAP-VAL construct changes the canonical rhomboid protease cleavage site motif AGGIIGG to VALIIGV. The transfected parasite populations were cloned. *CSP* and *TRAP* loci of wild-type control, CSΔN and TRAP-VAL parasite clones were genotyped by PCR to verify successful recombination and the presence of the desired mutations. Integration of the *CSΔN* copy at the correct location was verified by PCR of PbmCherry CSΔN clone B3 parasite line using previously described primer sets (\[[@bib9]\]; see [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} for primer sequences). PbmCherry TRAP-VAL clone A3 was genotyped by PCR using previously described primer sets (\[[@bib10]\]; see [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} for primer sequences). For both mutants, the presence of the desired mutation was confirmed by sequencing.

### Western blotting {#s4-3-2}

Wild-type control and CSΔN salivary gland sporozoites were lysed in reducing sample buffer, and 1.5 × 10^4^ sporozoites per lane were loaded and separated by SDS-PAGE and transferred to nitrocellulose membrane. The membrane was cut in between the markers for 52- and 76-kDa, and the top half was incubated with a 1:100 dilution of rabbit polyclonal antisera to the repeat region of TRAP, used as a loading control ([@bib10]), followed by anti-rabbit IgG conjugated to horseradish peroxidase (HRP). The bottom half of the blot was incubated with 1 μg/ml mouse monoclonal CSP antibody (clone 3D11, \[[@bib28]\]), followed by anti-mouse IgG, conjugated to HRP. HRP was visualized using enhanced chemiluminescence (GE Healthcare, United Kingdom).

### Immunofluorescence {#s4-3-3}

Wild-type control and CSΔN salivary gland sporozoites were fixed with 4% paraformaldehyde, blocked in 3% BSA and detected with a 1:100 dilution of polyclonal rabbit N-terminal CSP serum ([@bib9]) or with 1 μg/ml mouse monoclonal CSP antibody (clone 3D11, \[[@bib28]\]), followed by detection with Alexa-Fluor-488-conjugated anti--rabbit or anti-mouse IgG (Life Technologies, Durham, NC, United States). Samples were preserved in Prolong Gold mounting medium (Life Technologies) and imaged using phase-contrast and fluorescence microscopy on an upright Nikon E600, and images were acquired with a digital camera (DsRi1 Nikon).

### Determination of parasite liver load {#s4-3-4}

4- to 6-week-old Swiss Webster mice were infected with 10^4^ wild-type control or CSΔN salivary gland sporozoites, either by intravenous or intradermal injection. For intradermal inoculation, mice were lightly anaesthetized with ketamine/xylazine and maintained at 37°C on a slide warmer. Sporozoites were injected into the ear pinna in a total volume of 0.2 μl DMEM with a Flexifill microsyringe (World Precision Instruments, Sarasota, FL, United States). 36.5 hr after sporozoite inoculation, the livers of all mice were harvested, total RNA was isolated using Tri-reagent (Molecular Research Center, Cincinnati, OH, United States) and the parasite burden in the liver was quantified using reverse transcription (RT) with random hexamers, followed by real-time PCR with the SYBR green Kit (Applied Biosystems, Carlsbad, CA, United States) using primers specific for *P. berghei* 18S rRNA as outlined previously ([@bib7]). 10-fold dilutions of a plasmid construct containing the *P. berghei* 18S rRNA gene were used to create a standard curve.

### Determination of prepatent period {#s4-3-5}

Swiss Webster mice were lightly anesthetized by intraperitoneal injection of ketamine/xylazine and exposed for 30 min to the bites of *A. stephensi* infected with wild-type control or TRAP-VAL parasites. The onset of blood stage infection was determined by observation of Giemsa-stained blood smears, beginning on day 3 after inoculation.

Intravital imaging {#s4-4}
------------------

Sporozoites in the ear pinna of mice were imaged similar to a previously described protocol ([@bib2]). 4- to 5-week-old C57BL/6 mice from Taconic were lightly anesthetized by intraperitoneal injection of ketamine/xylazine (35--100 μg ketamine/gram body weight), and sporozoites were injected intradermally into the dorsal sheet of the ear pinna in a total volume of 0.2 μl using a NanoFil-10 μl syringe with a NF33BV-2 needle (World Precision Instruments). All experiments were completed within 60 min of salivary gland dissection to ensure that imaging and parasite conditions remained constant. By taping the ear pinna to a coverslip, the mouse was mounted on the platform of an inverted Zeiss Axio Observer Z1 microscope with a Yokogawa CSU22 spinning disk and a preheated temperature-controlled chamber at 30°C. For imaging of mosquito-bite inoculated sporozoites, infected mosquitoes were kept in a plexiglass tube with mesh screen and were allowed to probe in the portion of the ear pinnae immobilized on the microscope stage. Parasites were visualized using a 10× objective and magnified with a 1.6 Optovar, resulting in an x and y imaging volume of 500 μm × 500 μm. Z-slices were imaged with an exposure time of approximately 150 ms and time-lapse stacks with 3--5 slices spanning a total depth of 30--50 μm were captured at approximately 1 Hz over a total time of 4 min using an EMCCD camera (Photometrics, Tucson, AZ, United States) and 3i slidebook 5.0 software. The indicated time points after inoculation refer to the starting time of the 4-min acquisition. Images were projected into a single z-layer and the resulting two-dimensional data set was processed and manually tracked using Imaris software (Bitplane, Concord, MA, United States). For visualization of dermal blood vessels, mice were intravenously injected with 15 μg of rat anti-mouse CD31 coupled to Alexa-Fluor-647 (clone 390, Biolegend, San Diego, CA, United States), 2--4 hr prior to imaging.

Manual tracking and data analysis {#s4-5}
---------------------------------

### Statistical analysis {#s4-5-1}

Statistical analysis of scatter dot plots were analyzed using unpaired Student\'s *t*-test and statistical significance between samples is indicated with asterisks as follows \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001; \*\*\*\*p \< 0.0001; ns, nonsignificant (p \> 0.05). Track curvature analysis was tested for statistical significance using Kolmogorov--Smirnov two-sample test.

### Track projections {#s4-5-2}

Reconstructed sporozoite tracks were plotted to a common origin using the Imaris MATLAB Xtension ('plot tracks to common origin').

### MSD {#s4-5-3}

The MSD was calculated for parasites that exhibited motility and tracks spanning less than the total video time of 4 min were discarded. The MSD of wild-type control sporozoites over time included the following data points: 5 min (2 videos, 37 tracks), 10 min (14 videos, 179 tracks), 20 min (7 videos, 95 tracks), 30 min (9 videos, 129 tracks), 60 min (8 videos, 77 tracks) and 120 min (7 videos, 67 tracks). In order to be able to analyze the MSD from sporozoite populations obtained from videos with varying frame rates, the data were interpolated to a common time interval using the cubic spline function in GraphPad prism. Linear regression fitting was performed using GraphPad Prism software and suggested a linear relationship between MSD and time. To obtain the MSD of CSΔN and TRAP-VAL sporozoites, 179 wild-type control sporozoites were tracked in 12 videos and compared to 211 tracks obtained from 29 videos of CSΔN parasites and 215 tracks of TRAP-VAL sporozoites originating from 33 videos; all videos for this analysis were acquired 10 min after intradermal inoculation of sporozoites.

To generate the MSD of sporozoites moving in proximity to CD31-labeled vessels 10 min after intradermal injection, 18, 25, or 24 videos of wild-type control, CSΔN and TRAP-VAL sporozoites, respectively, were analyzed, and 313, 352, or 192 tracks of sporozoites moving in proximity to CD31-labeled vessels were generated. 163, 121, or 89 tracks of sporozoites moving in avascular areas of the dermis were produced from the same set of videos of wild-type control, CSΔN and TRAP-VAL sporozoites, respectively. To calculate the MSD of the obtained tracks with various duration times, all tracks were uniformly fragmented into tracks of 30 s in duration.

### Probability distribution {#s4-5-4}

The x and y position data of sporozoite tracks were exported, and the total displacement exhibited by sporozoites at the end of the 4-min videos, defined as the Euclidean distance between first and last track location, was calculated. The probability distribution P(r) of the final displacements was obtained by binning displacement data and dividing each bin by the total number of tracks to create a frequency-normalized histogram. Data analysis was performed via custom-written MATLAB software (<https://github.com/kevinkchiou/Malaria-Motility>).

### Apparent speed {#s4-5-5}

Apparent speed has previously been discussed ([@bib16]) as an estimation of the instantaneous speed and is calculated as the sum of distances between track locations, divided by the track duration. This measure is highly sensitive to the frame rate with which the video was acquired ([@bib16]) and to achieve consistent interval times across the entire data set, for the calculation of apparent speed we utilized only positional data in 3-s intervals, which is larger than the longest interval time present in the data set.

### Track straightness {#s4-5-6}

The track straightness is defined as the ratio of displacement to total track length and as a result can range between zero (entirely constrained track) and one (the track is a straight line) ([@bib5]). Notably, this ratio is highly sensitive to the track duration ([@bib5]) and therefore only tracks with the same duration were compared. To calculate the track straightness of wild-type control sporozoites over time, the tracks of meandering and linearly moving sporozoites tracked for the MSD analysis were used. To account for the percentage of circling sporozoites at the individual time point, 80 sporozoites continuously moving in the same circle were tracked, and the average track straightness of exclusively circling sporozoites was found to be 0.03. A number of tracks with this value were added to the analysis, representative for the percentages of circling sporozoites observed at the individual time point.

### Calculation of time spent in proximity to CD31-labeled vessel {#s4-5-7}

To obtain duration of motility near blood vessels in videos acquired 10 min after intradermal inoculation, motile sporozoites were tracked when observed to be circling around or gliding alongside CD31-labeled vessels. In a given video, the durations of all tracks were added and expressed as percentage of total motile time, which was calculated as number of motile sporozoites multiplied by the total video time. This analysis was performed on 33 videos of wild-type control, 31 videos of CSΔN, and 35 videos of TRAP-VAL sporozoites.

### Track curvature analysis {#s4-5-8}

The tracking data originating from manual differential tracking of sporozoites moving in proximity to CD31-labeled vessels as well as in avascular areas of the dermis were used to determine the curvature of these two sets of sporozoite tracks. To find the local curvature *κ*~*i*~ at data point *i* of a two-dimensional track, a circle is fit to position data along that track that are within a finite time window *T* = 10 s. In this case, the track curvature is the inverse of the fit radius, $\kappa_{i} = r_{i}^{- 1}$. The time window *T* serves two purposes: (1) to average out positional noise and (2) to maintain consistent time windows between data sets with different time intervals.

Consider a data point indexed by *i*. We denote the time--space coordinates of this point as (*t*~*i*~, *x*~*i*~, *y*~*i*~). We find all points along this track within *t*~*i*~ ± *T*/2 of which there are *N*. We denote the resulting coordinates of all those points as (*t*~1~, *x*~1~, *y*~1~) ,..., (*t*~*N*~, *x*~*N*~, *y*~*N*~). The time points associated with these positions all lie within *t*~*i*~ ± *T*/2 and satisfy the relation *t*~*i*~ − *T*/2 ≤ *t*~1~ \< ... \< *t*~*N*~ ≤ *t*~*i*~ + *T*/2. For a given data point, if this window exceeds the available track data, then we omit it and perform no fitting. If the track data properly spans the time window around *t*~*i*~, then we collect the *N* ≥ 3 points and fit a center and radius (*x*~*c*~, *y*~*c*~, *r*)~*i*~ to the positions. The fit is performed via linear least-squares regression as detailed below. The general equation of a circle in the (*x*, *y*) plane centered at (*x*~*c*~, *y*~*c*~) with radius *r* is$$\left( {x - x_{c}} \right)^{2} + \left( {y - y_{c}} \right)^{2} = r^{2}.$$

The least-squares regression for a set of positional data {(*x*~*i*~, *y*~*i*~)} of size *N* to a circle benefits from the fact that the distance of the closest approach is along the radial direction. As a result, the least-squares residual is$$R^{2} = \sum\limits_{i = 1}^{N}\left( {\sqrt{\left( {x_{i} - x_{c}} \right)^{2} + \left( {y_{i} - y_{c}} \right)^{2}} - r} \right)^{2}.$$

This equation is non-quadratic in the circle parameters (*x*~*c*~, *y*~*c*~, *r*); therefore no linear regression solution exists as written (although non-linear regression techniques can be applied).

However, a reorganization of the equation for a circle and computing the squared residual of *r*^2^ (instead of *r*) allows for solution by linear regression. Expanding as$$x^{2} + y^{2} = r^{2} - x_{c}^{2} - y_{c}^{2} + 2xx_{c} + 2yy_{c},$$we designate a new parameter $\alpha = r^{2} - x_{c}^{2} - y_{c}^{2}$. The modified residual is then$$R_{\text{mod}}^{2} = \sum\limits_{i = 1}^{N}\left( {\alpha + 2x_{i}x_{c} + 2y_{i}y_{c} - x_{i}^{2} - y_{i}^{2}} \right)^{2}.$$

Within the sum of squares, the terms are all either (1) linear with respect to the parameters (*x*~*c*~, *y*~*c*~, *α*) or (2) constant. This is solvable by linear regression on the circle parameters.

We perform said linear regression by solving the associated matrix equation. Let us define the vectorized parameter *z* = (*x*~*c*~, *y*~*c*~, *α*). Residual minimization over *z* becomes$$\underset{z}{\text{min}}\, R_{\text{mod}}^{2} = \underset{z}{\text{min}}\left\| {A_{ij}z_{j} - b_{i}} \right\|^{2}$$where *j* ∈ {1, 2, 3} indexes the fit parameters (*x*~*c*~, *y*~*c*~, *α*), and *i* ∈ {1,...,*N*} indexes the data entries. Then best-fit parameters $\overline{z}$ that minimize this residual are then $\overline{z} = \left( A^{T}A \right)^{- 1}A^{T}b$ where,$${\overline{z} = \begin{pmatrix}
{\overline{x}}_{c} \\
{\overline{y}}_{c} \\
\overline{\alpha} \\
\end{pmatrix},A = \begin{pmatrix}
{2x_{1}} & {2y_{1}} & 1 \\
 \vdots & \vdots & \vdots \\
{2x_{N}} & {2y_{N}} & 1 \\
\end{pmatrix},b = \begin{pmatrix}
{x_{1}^{2} + y_{1}^{2}} \\
 \vdots \\
{x_{N}^{2} + y_{N}^{2}} \\
\end{pmatrix}}.$$

Here, *A*^*T*^ denotes the transpose of the matrix *A*, and (*A*^*T*^*A*)^−1^ is the matrix inverse of *A*^*T*^*A*.

Once best-fit values $\left( {\overline{x}}_{c},{\overline{y}}_{c},\overline{\alpha} \right)$ are obtained, the best fit curvature $\overline{\kappa}$ can be computed by its relation to $\overline{z}$:$$\begin{matrix}
{\overline{\kappa} = \left. \sqrt{\left( \overline{\alpha} \right. + {\overline{x}}_{c}^{2} + {\overline{y}}_{c}^{2}} \right)^{- 1}.} \\
\end{matrix}$$

Data analysis was performed via custom-written MATLAB software, available on GitHub at <https://github.com/kevinkchiou/Malaria-Motility>. The collection $\left\{ {\overline{\kappa}}_{i} \right\}$ computed by this algorithm are aggregated and plotted as a histogram.
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Decision letter
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United States

eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Longitudinal analysis of *Plasmodium* sporozoite motility in the dermis reveals component of blood vessel recognition" for consideration at *eLife*. Your article has been favorably evaluated by Prabhat Jha (Senior Editor), a Reviewing Editor, and three reviewers.

Your study regarding migration of dermally delivered *Plasmodium* sporozoites received favorable reviews from all the reviewers. The results convincingly show the difference between "avascular" and "vascular" migration of the parasites using both wild type and mutant parasites. The data acquisition is deemed accurate and the quantified data carefully evaluated. Overall, as a technical tour-de-force, the study provides important new insights into in vivo malaria sporozoite behavior during the critical interval between injection into the dermis and entry into blood vessels. The reviewers stated that the quality of the experiments and the importance of the observations merit an acceptance of the manuscript.

Notwithstanding, the reviewers had several major concerns, and collectively it was decided that the final acceptance is pending your responses to their comments.

1\) Several questions arose in regard to the use of CD31 labeling. A concern was expressed whether labeling with CD31 might have interfered with sporozoite migration and invasion of the vasculature. Another concern was specificity. Because CD31 also labels lymphatic vasculature, the authors need to document sporozoite invasion into each of the CD31+ vessels. Otherwise, these cannot be called blood vessels or the motility cannot be referred to as vascular motility. This should be corrected throughout the text. Finally, there was concern considering the method of analysis. The proximity of the parasites to the CD31+ vessels was scored manually, which can lead to errors. Therefore, it would be helpful if the authors would perform analyses on one of the 3D datasets to validate that the numbers obtained from the maximum intensity projections are correct.

2\) The interpretation that *Plasmodium* parasites switch the mode of their motility to engage blood vessel should be toned down. This observation has previously been reported and the current data proposing such a change from fast to slow when engaging vessels are not convincing. For the quantification of the parasites that are changing the mode of motility it is essential to consider that while some parasites are losing straight/fast mode, the numbers of the parasites with curved/slow mode of motility is not increasing. Hence, it is the proportion, rather than the number, that changes.

3\) It appears that some of the work has not been cited properly and some previously reported observations have been excluded from the Discussion. Among others, the authors should include published works on sporozoite gliding by [@bib25], work by [@bib1] on decreased sporozoite speed on contacting blood vessels and work by Battista, Frischenechet and Schwarz (2014) on the curvature of sporozoites fitting the capillaries. The current results should be discussed further in the context of observations reported by Hellman (2011). It is suggested that the authors consider the possibility that the current data could be explained by simple physical constraints analogous to the microfabricated pillers in the Hellman paper.

4\) Another comment relates to the mutant parasites that were shown to be impaired in their ability to invade blood vessels, despite the fact that they found blood vessels and remained associated with them. Although the authors do discuss it, it appears that the discussion may be inadequate in providing a cogent explanation for this observation.

5\) A revision of the title has been suggested so that it precisely reflects the findings. A clarification should be provided -- in your already well-written manuscript -- about the use of the term "vascular," which does mean that the sporozoites are inside the vessels.

6\) A rather important question was posed regarding different migration patterns caused by the sporozoite delivery route: by a mosquito bites versus a syringe.

7\) The legends need to include more detail about the identification of the sporozoites that invade the vessels and the video should be labeled more precisely.

10.7554/eLife.07789.025

Author response

We have responded to the editor's request to move all supplemental methods into the main body of the paper. This applied to the methodology for generating and verifying the mutants and to the mathematical analysis used for track curvature analysis, which are now in the Methods section of the manuscript.

1\) Several questions arose in regard to the use of CD31 labeling. A concern was expressed whether labeling with CD31 might have interfered with sporozoite migration and invasion of the vasculature.

We agree with reviewers that interference of CD31-labeling with sporozoite motility and exit from the dermis is a valid concern. In the original version of the manuscript, in Figure 5--figure supplement 2, we showed that CD31-labeling did not interfere with entry into dermal blood or lymphatic vessels, as the sporozoite invasion rates are similar in videos acquired in mice with and without CD31-labeled blood vessels. However, we had not looked at the effect of CD31 labeling on sporozoite migration. In part, this was because vessels were not labeled in the majority of the videos used to determine MSD, they were only labeled in a subset of the 10-minute videos, since this was the time point used for quantification of vessel entry. We went back to the videos used for the MSD analysis ([Figure 1B](#fig1){ref-type="fig"}) and reanalyzed the 10 minute time point data to separately calculate the MSD of sporozoites in videos with and without CD31-labeling. We found that the MSD in the two populations was similar and these data are now shown as a new panel of [Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}.

Another concern was specificity. Because CD31 also labels lymphatic vasculature, the authors need to document sporozoite invasion into each of the CD31+ vessels. Otherwise, these cannot be called blood vessels or the motility cannot be referred to as vascular motility. This should be corrected throughout the text.

The reviewers are correct that CD31 is a pan-endothelial marker, expressed by both lymphatic and blood vessel endothelial cells, although the expression level on lymphatic vessels is lower than on blood vessels (Podgrabinska et al., Molecular characterization of lymphatic endothelial cells, PNAS, Vol 99:16069, 2002). It is important to note, and we neglected to do so in the original manuscript, that the methodology we used does not result in CD31 staining of lymphatic vessels. We injected the anti-CD31 intravenously into the blood circulation 2-3 hours prior to the imaging experiment, and as a result it primarily stained blood vessels, since at this point the antibody has not crossed into the extravascular space to be drained into the lymphatic system. For imaging of lymphatic vessels, labeling antibodies are typically injected a day prior to the imaging experiment (Sarkisyan et al., Real-time differential labeling of blood, interstitium, and lymphatic and single-field analysis of vasculature dynamics in vivo, Am. J. Physiol. Cell Physiol., 2012). Included as a new figure supplement, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, is a still image obtained from live microscopy of a mouse ear in which anti-LYVE-1 antibody, specific for lymphatics, was inoculated intravenously 24 hours prior to imaging and anti-mouse CD31 antibody was inoculated 3 hours prior to imaging. No co-localization is observed, indicating that in our protocol, antibodies to CD31 do not label lymphatics. Lastly, given the unique structural characteristics of lymphatic capillaries, which possess frequent blind endings and are wider and flatter than blood vessels (Tripp et al., The lymph vessel network in mouse skin visualized with antibodies against the hyaluronan receptor LYVE-1, Immunobiology, 213:715--28, 2008), we are confident that the vessels stained in our experiments are blood and not lymphatic vessels. We have changed the manuscript to clarify this important issue (see the subsection "Sporozoites recognize dermal CD31+ blood vessels").

Finally, there was concern considering the method of analysis. The proximity of the parasites to the CD31+ vessels was scored manually, which can lead to errors. Therefore, it would be helpful if the authors would perform analyses on one of the 3D datasets to validate that the numbers obtained from the maximum intensity projections are correct.

We agree with the reviewers that 3D tracking would be ideal and that tracking sporozoites in the maximum projections may lead to errors. However, the acquired stacks have virtually no 3D resolution. Given the high gliding speed of sporozoites, entire stacks have to be acquired with short interval times, and since exposure times of up to 200 ms per capture are necessary to visualize the parasites in the dermis, we were only able to acquire 3-5 slices using a 10x objective with maximal pinhole setting. This amounted to only semi-confocal data, with essentially no z-resolution, which does not allow for tracking in three dimensions. While we agree that in individual cases we may have scored sporozoites as being close to vessels when they were not, given the number of data points we acquired, we do not think that this is a problem, particularly since these false positives would only minimize the differences between vascular and avascular motility, as this would not be an issue with sporozoites moving far from vessels.

*2) The interpretation that* Plasmodium *parasites switch the mode of their motility to engage blood vessel should be toned down. This observation has previously been reported and the current data proposing such a change from fast to slow when engaging vessels are not convincing.*

The reviewers are correct, the decrease in sporozoite gliding speed upon approach of a blood vessel has previously been documented (Amino et al., Nat. Med., 2006) and we have now discussed this previous finding in the Discussion: "These data build upon and solidify the previous observation of Amino et al., who quantified the speed of a small number of sporozoites gliding around blood vessels and reported a decrease after contact with the vessel". We agree that the initial seminal study of Amino et al. is the first observation of this slow-down, however this study only looked at a few sporozoites, while our results are based on hundreds of measurements, thus really solidifying this finding. We were surprised to read the statement of the data not being convincing, since the editor's letter stated: "The results convincingly show the difference between "avascular" and "vascular" migration \[...\] the study provides important new insights into in vivo malaria sporozoite behavior during the critical interval between injection into the dermis and entry into blood vessels." While the change in speed upon approach of a blood vessel is moderate, it is highly significant ([Figure 2B](#fig2){ref-type="fig"}) and hopefully the reviewers are persuaded to agree.

For the quantification of the parasites that are changing the mode of motility it is essential to consider that while some parasites are losing straight/fast mode, the numbers of the parasites with curved/slow mode of motility is not increasing. Hence, it is the proportion, rather than the number, that changes.

We completely agree with the reviewers and now include this information. We expressed the data as percentages because many of our videos were not part of complete time courses. Thus, in many instances we do not know the proportion of sporozoites that remain in the field at the late time points compared to earlier time points. Nonetheless, we do have two complete time courses, in which the same site was imaged from 5 to 120 minutes. These data were included in the original analyses shown in [Figure 1B-F](#fig1){ref-type="fig"}. We now use them to address the reviewers' concern and have generated a supplement to [Figure 1](#fig1){ref-type="fig"} ([Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}). Two things become evident when we visualize the data this way. First, at 20 and 30 minutes after inoculation, while the total number of sporozoites and the number of non-motile sporozoites does not change significantly, the number of sporozoites moving in a linear fashion decreases and the number that are circling continuously throughout the video increases. These data are consistent with our observation of an initial period of high dispersal motility, followed by more constrained motility. However, when we look at the very late time points, 60 and 120 minutes after inoculation, these observations are confounded by the 20% and 40% fewer sporozoites in the field respectively, and by the significantly increased number of non-motile sporozoites. We have therefore added more discussion of these data in the Results section and in the Discussion: "In contrast to previous reports of apparently random motility \[...\] indicates that there is a specific recognition event that leads to this change."

*3) It appears that some of the work has not been cited properly and some previously reported observations have been excluded from the Discussion. Among others, the authors should include published works on sporozoite gliding by* [@bib25]*, work by* [@bib1] *on decreased sporozoite speed on contacting blood vessels and work by Battista, Frischenechet and Schwarz (2014) on the curvature of sporozoites fitting the capillaries.*

We have inserted references to the listed studies and more fully discussed the studies we had already cited. The Vanderberg et al. study (Int. J. Parasitol., 2004) is cited with other reports of sporozoite motility being important for dermal exit. We now mention the previous report of decreased sporozoite gliding speed in proximity to blood vessels (Amino et al., Nat. Med., 2006) in the Discussion. Additionally, we added a discussion on early descriptions of sporozoite geometry and how an in silico model, predicting the sporozoite\'s ability to change its curvature (Battista et al., Phys. Rev. E. Stat. Nonlin. Soft. Matter Phys., 2014) is supportive of our data.

The current results should be discussed further in the context of observations reported by Hellman (2011). It is suggested that the authors consider the possibility that the current data could be explained by simple physical constraints analogous to the microfabricated pillers in the Hellman paper.

The reviewers make a valid point that it has previously been discussed that the distance between obstacles in vitro and different dermal environments in vivo can induce changes in sporozoite motility, which leads to the hypothesis that obstacle distances in the dermis guide sporozoite migration (Hellman et al., PLoS Pathog., 2011). However, we are reporting the first evidence of the ability of the sporozoite to alter motility in response to a specific host structure, suggesting sporozoite migration is responsive to host signals more complex than simple physical constraints. We think that more intravital imaging needs to be performed with visualization of components of the extracellular matrix and host cells other than endothelial cells in order to shed light on the host-pathogen interactions relevant for blood vessel recognition. However, we have extended the Discussion to include the findings of Hellman et al., and to allow the reader to put our findings into the perspective of what has previously been found.

4\) Another comment relates to the mutant parasites that were shown to be impaired in their ability to invade blood vessels, despite the fact that they found blood vessels and remained associated with them. Although the authors do discuss it, it appears that the discussion may be inadequate in providing a cogent explanation for this observation.

We agree that there was not a cogent explanation for this and, in large part, it is because more work is needed to fully explain this observation. We have, however, modified and added to our original text to improve clarity and flesh out some of our hypotheses as to what could cause the phenotype that we observe. Please see in the Results section: "These data point to an additional impairment in blood vessel entry, i.e. even when they do contact blood \[...\] results in their inability to complete the entry process."

5\) A revision of the title has been suggested so that it precisely reflects the findings. A clarification should be provided -- in your already well-written manuscript -- about the use of the term "vascular," which does mean that the sporozoites are inside the vessels.

The question of the title goes back to point number 4. We believe that the current title accurately reflects our findings. Regarding the term "vascular" -- we now see the confusion that this could cause. We have gone back and changed all such uses of the word to "perivascular" which should clarify its meaning.

6\) A rather important question was posed regarding different migration patterns caused by the sporozoite delivery route: by a mosquito bites versus a syringe.

We agree that this is an important point and had included a preliminary analysis of sporozoite migration patterns after inoculation by mosquito bite in the original manuscript ([Figure 1--figure supplement 2](#fig1s2){ref-type="fig"}). For this figure, we combined two imaging time courses of mosquito-inoculated sporozoites and analyzed their MSD and motility patterns. As shown, we found no significant difference in sporozoite behavior in terms of MSD and proportion of manually counted sporozoite motility patterns. We have also added more commentary on these data, at the end of the first section of the Results.

7\) The legends need to include more detail about the identification of the sporozoites that invade the vessels and the video should be labeled more precisely.

We have amended the legend to [Figure 5E](#fig5){ref-type="fig"}, as well as the fifth section of the Results, to give more details on the identification of invasion events. Compared to previous video material (Amino et al., Nat. Med., 2006), blood vessel invasion events in videos that include CD31-labeling are not always characterized by the sudden increase in speed, which is a result of our slower acquisition speed (due to the capture of two channels). The sporozoite in circulation is frequently carried out of the field of view before the next frame is captured. We therefore altered our description of the manual invasion counts and now define blood vessel invasion by "a sudden increase in speed or visual entry of the blood vessel and disappearance out of the field of view". Since the frame rate with which images were acquired was higher in videos without CD31-labeling, these videos allow the viewer to see the sudden increase in speed. We therefore included an additional video ([Video 8](#video8){ref-type="other"}), in which two blood vessel invasion events, characterized by the sudden increase in speed, are clearly visible.
